1-May-2026
Dentrix Ascend Introduces Next Generation Clinical Workflow Built with AWS
Business Wire (Thu, 30-Apr 6:30 AM ET)
Business Wire (Tue, 28-Apr 10:04 AM ET)
Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026, at 8:00 A.M. ET
Business Wire (Tue, 21-Apr 6:30 AM ET)
Henry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of Stockholders
Business Wire (Wed, 8-Apr 7:00 AM ET)
Business Wire (Wed, 18-Mar 6:30 AM ET)
Henry Schein One Unveils the Next Era of Dentrix Ascend for DSOs and Growth-Focused Practices
Business Wire (Tue, 10-Mar 6:30 AM ET)
Henry Schein to Participate in Upcoming Investor Conferences in March
Business Wire (Tue, 3-Mar 6:30 AM ET)
Globe Newswire (Thu, 26-Feb 8:19 AM ET)
Business Wire (Tue, 24-Feb 6:00 AM ET)
Business Wire (Thu, 19-Feb 6:30 AM ET)
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
Henry Schein trades on the NASDAQ stock market under the symbol HSIC.
As of May 1, 2026, HSIC stock price declined to $73.93 with 1,740,687 million shares trading.
HSIC has a beta of 0.40, meaning it tends to be less sensitive to market movements. HSIC has a correlation of 0.05 to the broad based SPY ETF.
HSIC has a market cap of $9.24 billion. This is considered a Mid Cap stock.
Last quarter Henry Schein reported $3 billion in Revenue and $1.34 earnings per share. This beat revenue expectation by $99 million and exceeded earnings estimates by $.04.
In the last 3 years, HSIC traded as high as $89.29 and as low as $60.01.
The top ETF exchange traded funds that HSIC belongs to (by Net Assets): VTI, VOO, VB, RSP, VBR.
HSIC has underperformed the market in the last year with a price return of +14.7% while the SPY ETF gained +30.4%. HSIC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.1% and -6.2%, respectively, while the SPY returned +4.4% and +1.5%, respectively.
HSIC support price is $73.39 and resistance is $75.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSIC shares will trade within this expected range on the day.
